Gore S M, Brettle R P, Burns S M, Lewis S C
MRC Biostatistics Unit, Cambridge, U.K.
J Infect. 1998 Sep;37(2):166-72. doi: 10.1016/s0163-4453(98)80172-2.
To estimate the early death-rate in HIV infected injectors whose HIV infection was during the injection-related HIV outbreak in Lothian region in Scotland in 1983-1984, which was coincident with Hepatitis B transmissions.
Regional Virus Laboratory in Edinburgh.
Sera from 1983-1984, originally received for Hepatitis B surface antigen testing, from individuals aged 15-55 years who were positive for Hepatitis B surface antigen in 1983-1984 (group A: census) or tested negative but were at high risk for blood-borne virus transmission according to their reason for testing (group B: 50% sample).
Survival status of individuals in groups A and B who had not been diagnosed with HIV disease by the end of December 1995 was checked against the deaths' records of the Registrar General for Scotland. Stored sera from 1983-1984 for patients who had died early (that is: in 1983-1984) were tested anonymously for HIV and Hepatitis C antibodies; and prior to testing, causes of death were scored by RPB according to the likelihood of their being HIV or drugs related.
Three early deaths were found in group A patients who were not known to be HIV infected. None of the deaths was likely to be HIV-related; the sera were not tested in order not to risk deductive disclosure. Twenty-four early deaths were found in group B patients who were not known to be HIV-infected, five of whom were both HIV and Hepatitis C antibody positive, and one other was HIV antibody negative but Hepatitis C positive. Reclassification after unlinked anonymous testing and multiplying up of the group B results (to account for 50% sample) gave the early death rate (that is: in 1983-1986) as 15/155 (10%) for HIV-infected drug users (95% CI: 6%-13%).
Injection-related outbreaks of HIV infection in Lothian in 1983-1984 and at Glenochil Prison in 1993 were each associated with substantial--estimated 10%--early death-rate in HIV-infected injectors. Both HIV outbreaks were coincident with Hepatitis B transmissions, which may be relevant. Further investigations of the death-rate within 2 years of HIV infection are warranted in other exposure categories than injection-related and for injectors who have been immunized against Hepatitis B.
评估1983 - 1984年在苏格兰洛锡安地区与注射相关的HIV疫情期间感染HIV的注射吸毒者的早期死亡率,该疫情与乙型肝炎传播同时发生。
爱丁堡地区病毒实验室。
1983 - 1984年的血清,最初用于乙型肝炎表面抗原检测,来自1983 - 1984年乙型肝炎表面抗原呈阳性的15 - 55岁个体(A组:普查),或检测呈阴性但根据其检测原因有血源病毒传播高风险的个体(B组:50%样本)。
对照苏格兰总登记官的死亡记录,检查截至1995年12月底未被诊断患有HIV疾病的A组和B组个体的生存状况。对早期死亡(即1983 - 1984年)患者1983 - 1984年储存的血清进行HIV和丙型肝炎抗体匿名检测;在检测前,RPB根据死亡与HIV或毒品相关的可能性对死因进行评分。
在未知感染HIV的A组患者中发现3例早期死亡。这些死亡均不太可能与HIV相关;为避免推断性披露风险,未对血清进行检测。在未知感染HIV的B组患者中发现24例早期死亡,其中5例HIV和丙型肝炎抗体均呈阳性,另1例HIV抗体阴性但丙型肝炎抗体呈阳性。在进行不关联匿名检测并扩大B组结果(以考虑50%样本)后重新分类,得出HIV感染吸毒者的早期死亡率(即1983 - 1986年)为15/155(10%)(95%置信区间:6% - 13%)。
1983 - 1984年洛锡安地区以及1993年格莱诺基尔监狱与注射相关的HIV疫情,均与HIV感染注射吸毒者较高的估计10%的早期死亡率相关。这两次HIV疫情均与乙型肝炎传播同时发生,这可能具有相关性。对于除注射相关之外的其他暴露类别以及已接种乙型肝炎疫苗的注射吸毒者,有必要进一步调查HIV感染后2年内的死亡率。